Most Awaited Q3 Sale is back. Upto 30% discount on every report.

RNAi Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 26
SKU : PH4269
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350$3480
Multiple User
$4850$3880
Enterprise User
$7850$6280
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the RNAi Therapeutics Market?
The Projected CAGR value is 17.4%.
Who are the key players in RNAi Therapeutics Market?
Key players are Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation, Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics, Inc.
Which is the fastest-growing region in the RNAi Therapeutics Market?
Asia Pacific is the fastest-growing region in the RNAi Therapeutics Market.
Which is the Largest Market Share in the RNAi Therapeutics Market?
North America is the Largest Market Share in RNAi Therapeutics Market.
Related Reports
pharmaceuticals

Dengue Vaccine Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 20
Starting from

$4350

pharmaceuticals

Exocrine Pancreatic Insufficiency Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 15
Starting from

$4350

pharmaceuticals

Meningitis Vaccines Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 04
Starting from

$4350

pharmaceuticals

DTaP Vaccine Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 10
Starting from

$4350

pharmaceuticals

DNA Vaccines Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 11
Starting from

$4350

pharmaceuticals

Ion Channel Modulators Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 03
Starting from

$4350